Resources

Type of publications
Regions
Diseases

5255 results found

2023 ∙ Di Spirito, F. Pantaleo, G. Di Palo, M. P. Amato, A. Raimondo, A. Amato, M.

Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review

  • Adolescents
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Puspitasari, M. Sattwika, P. D. Rahari, D. S. Wijaya, W. Hidayat, A. R. P. Kertia, N. Purwanto, B. Thobari, J. A.

Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ishisaka, Y. Watanabe, A. Aikawa, T. Kanaoka, K. Takagi, H. Wiley, J. Yasuhara, J. Kuno, T.

Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Chan, P. S. F. Fang, Y. Kawuki, J. Chen, S. Liang, X. Mo, P. K. H. Wang, Z.

Parental Acceptance, Parental Hesitancy, and Uptake of Seasonal Influenza Vaccination among Children Aged 6–59 Months: A Systematic Review and Meta-Analysis

  • Parents/caregivers
  • Influenza
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Hakim, F. E. Riaz, K. Farooq, A.

Pediatric herpes zoster ophthalmicus: a systematic review

  • Newborn
  • Children
  • Adolescents
  • Herpes zoster
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Knuf, Markus Charkaluk, Marie-Laure The Nguyen, Phung Nguyen Salamanca de la Cueva, Ignacio Kobrunner, Petra Mason, Lauren Duchenne, Maurine Berlaimont, Valerie

Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review

  • Newborn
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Tessier, E. Newport, D. Tran, A. Nash, S. G. Mensah, A. A. Yun Wang, T. Shantikumar, S. Campbell, H. Amirthalingam, G. Todkill, D.

Pertussis immunisation strategies to optimise infant pertussis control: A narrative systematic review

  • Newborn
  • Children
  • Pertussis
  • Efficacy/effectiveness
  • Administration
  • Coverage
Methodological quality (AMSTAR 2):
Low
2023 ∙ Yong, S. J. Halim, A. Liu, S. Halim, M. Alshehri, A. A. Alshahrani, M. A. Alshahrani, M. M. Alfaraj, A. H. Alburaiky, L. M. Khamis, F. Muzaheed, None AlShehail, B. M. Alfaresi, M. Al Azmi, R. Albayat, H. Al Kaabi, N. A. Alhajri, M. Al Amri, K. A. S. Alsalman, J. Algosaibi, S. A. Al Fares, M. A. Almanaa, T. N. Almutawif, Y. A. Mohapatra, R. K. Rabaan, A. A.

Pooled rates and demographics of POTS following SARS-CoV-2 infection versus COVID-19 vaccination: Systematic review and meta-analysis

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Samimisedeh, P. Jafari Afshar, E. Tayebi, A. Rastad, H.

Post-acute midterm follow-up cardiac MRI findings and clinical outcomes in patients with COVID-19 vaccine-associated myocarditis: a comprehensive systematic review and meta-analysis

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ghaderi, S. Mohammadi, S. Heidari, M. Sharif Jalali, S. S. Mohammadi, M.

Post-COVID-19 Vaccination CNS Magnetic Resonance Imaging Findings: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...